Bio X Cell InVivoSIM™
Biosimilar monoclonal antibodies - with 15% discount
Bio X Cell InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic.
Features of Bio X Cell InVivoSIM™ antibodies:
- greater than 95% purity
- free of preservatives, stabilizers, and carrier proteins
- screened for murine pathogens and protein aggregation
- binding validation via immunoblot
- less than 1 endotoxin unit per milligram guaranteed
InVivoSIM™ antibodies are for Research Use Only (RUO) and are not for therapeutic use.
Art. Nr. | Product Name | Applications |
---|---|---|
BXC-SIM0001 | InVivoSIM™ anti-human TNFα (Adalimumab Biosimilar) | TNFα neutralization; FC, ELISA; IF; IP; IHC; WB |
BXC-SIM0002 | InVivoSIM™ anti-human EGFR (Cetuximab Biosimilar) | GFR blockade; ELISA; FC |
BXC-SIM0003 | InVivoSIM™ anti-human PD-1 (Nivolumab Biosimilar) | Blocking of PD-1/PD-L signaling; FC; IHC; WB |
BXC-SIM0004 | InVivoSIM™ anti-human CTLA-4 (Ipilimumab Biosimilar) | CTLA-4 neutralization; FC; ELISA; WB |
BXC-SIM0005 | InVivoSIM™ anti-human HER2 (Trastuzumab Biosimilar) | FC; ELISA; IHC; WB |
BXC-SIM0006 | InVivoSIM™ anti-human TNFα (Infliximab Biosimilar) | TNFα neutralization; FC; ELISA; WB |
BXC-SIM0007 | InVivoSIM™ anti-human VEGF (Bevacizumab Biosimilar) | VEGF neutralization; FC; ELISA; IP |
BXC-SIM0008 | InVivoSIM™ anti-human CD20 (Rituximab Biosimilar) | FC; ELISA; WB |
BXC-SIM0009 | InVivoSIM™ anti-human PD-L1 (Atezolizumab Biosimilar) | FC; WB |
BXC-SIM0010 | InVivoSIM™ anti-human PD-1 (Pembrolizumab Biosimilar) | FA |
BXC-SIM0011 | InVivoSIM™ anti-human C5 (Eculizumab Biosimilar) | FA, ELISA, IP |
BXC-SIM0012 | InVivoSIM™ anti-human VEGFR-2 (Ramucirumab Biosimilar) | FA, IHC, FC |
BXC-SIM0013 | InVivoSIM™ anti-human IL-17A (Secukinumab Biosimilar) | FA, ELISA, IF, IHC, FC |
BXC-SIM0014 | InVivoSIM™ anti-human IL-6R (Tocilizumab Biosimilar) | FA, ELISA |
BXC-SIM0015 | InVivoSIM™ anti-human LAG-3 (Relatlimab Biosimilar) | ELISA |
BXC-SIM0016 | InVivoSIM™ anti-human IgE (Omalizumab Biosimilar) | ELISA, FC |
12.10.2022
Labortops #4
Super Sale: up to 70% off labware
BIOZOL End-Of-Year P...
Up to 30 % discount on selected suppliers
iLite® Cell-Based So...
Reporter gene assays from Svar
Up to 50 % discount
Our current fall offers
Autumn conferences
Meet BIOZOL in Frankfurt, Bremen, and Düsseldorf